BioXcel Therapeutics (BTAI) Net Cash Flow (2017 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Net Cash Flow of -$11.6 million for Q1 2026, down 1098.88% year-over-year from $1.2 million in Q1 2025, and down 35.2% quarter-over-quarter from -$8.6 million in Q4 2025.
BioXcel Therapeutics (BTAI) Net Cash Flow (2017 - 2026) Analysis & Trends
BioXcel Therapeutics' Net Cash Flow history runs 10 years deep, the most recent figure standing at -$11.6 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 1098.88% year-over-year to -$11.6 million; the TTM figure through Mar 2026 stood at -$13.8 million (up 67.93% YoY), while the FY2025 annual figure was -$1.1 million, up 96.9% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$11.6 million, down from -$8.6 million in the prior quarter.
- The five-year high for Net Cash Flow was $18.7 million in Q3 2025, with the low at -$38.6 million in Q4 2022.
- The 5-year median for Net Cash Flow is -$15.9 million (2024), against an average of -$16.6 million.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow plunged 3202.64% in 2023, then jumped 218.01% in 2025.
- BioXcel Therapeutics' Net Cash Flow stood at -$38.6 million in 2022, then jumped by 35.89% to -$24.7 million in 2023, then soared by 57.43% to -$10.5 million in 2024, then advanced by 18.7% to -$8.6 million in 2025, then plunged by 35.2% to -$11.6 million in 2026.
- Business Quant data shows BTAI's Net Cash Flow at -$11.6 million in Q1 2026, -$8.6 million in Q4 2025, and $18.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.29 Mn | 24.29 Mn | 160,000.00 | -3.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.38 Mn |
| Jun 30, 2026 | -3.38 Mn |
| Mar 31, 2026 | -11.58 Mn |
| Mar 31, 2026 | -11.58 Mn |
| Dec 31, 2025 | -8.56 Mn |
| Dec 31, 2025 | -8.56 Mn |
| Sep 30, 2025 | 18.75 Mn |
| Sep 30, 2025 | 18.75 Mn |
| Jun 30, 2025 | -12.44 Mn |
| Jun 30, 2025 | -12.44 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | -10.53 Mn |
| Dec 31, 2024 | -10.53 Mn |
| Sep 30, 2024 | -15.88 Mn |
| Sep 30, 2024 | -15.88 Mn |
| Jun 30, 2024 | -17.87 Mn |
| Jun 30, 2024 | -17.87 Mn |
| Mar 31, 2024 | 8.92 Mn |
| Mar 31, 2024 | 8.92 Mn |